Form D · Biotechnology
Impulse Dynamics plc
Dublin 2, L2 · CIK 0001823293
Offering snapshot reported Mar 6, 2025 · SEC filing
- Reported sold
- $84.1M Offering amount: $140M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 20, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 6, 2025 | Initial | $84,130,000 | No comparison | 20 | SEC filing |
| May 20, 2024 | Initial | $136,499,993 | No comparison | 11 | SEC filing |
| Jul 31, 2023 | Amendment | $91,385,181 | $55,185,180vs May 25, 2022 | 26 | SEC filing |
| May 25, 2022 | Amendment | $36,200,001 | $5,200,001vs Feb 24, 2022 | 14 | SEC filing |
| Feb 24, 2022 | Initial | $31,000,000 | No comparison | 11 | SEC filing |
| Jan 15, 2021 | Initial | $60,000,000 | No comparison | 4 | SEC filing |
| Oct 29, 2020 | Initial | $45,250,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-540092
Source: Form D, filed Mar 6, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Bae | Executive |
| John K. Bakewell | Director |
| Shlomo Ben Haim | Director |
| Joseph H. Capper | Director |
| Harriss T. Currie | Executive |
| Joyce Erony | Director |
| Robert Faulkner | Director |
| Gerald M Haines | Executive |
| Shing Yan Ho | Director |
| Jeffrey B Jump | Director |
| Simos I Kedikoglou | Director, Executive |
| Simeon I Kedikoglou | Director, Executive |
| Simeon I. Kedikoglou, M.D. | Director, Executive |
| Glenn P. Muir | Director |
| Shlomi Nachman | Director |
| Guido Neels | Director |
| Antony W Owers | Director |
| Konstantin Poukalov | Director |
| David Prutchi | Executive |
| David Prutchi, Ph.D. | Executive |
| Daniel Scavilla | Director |
| Jason Spees | Director, Executive |
| James R. Tobin | Director |
| Scott Way | Executive |
| Shing H Yan | Director |
| Rui Yang | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
70 Sir John Rogersons Quay
Dublin 2, L2, D02 R296
Dublin 2, L2, D02 R296